Get the Stockscreener App
1.12
1.32%
-0.015
After Hours:
1.11
-0.01
-0.89%
Tela Bio Inc stock is traded at $1.12, with a volume of 22,191.
It is down -1.32% in the last 24 hours and down -2.61% over the past month.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
See More
Previous Close:
$1.135
Open:
$1.14
24h Volume:
22,191
Relative Volume:
0.13
Market Cap:
$49.87M
Revenue:
$63.15M
Net Income/Loss:
$-40.30M
P/E Ratio:
-0.6707
EPS:
-1.67
Net Cash Flow:
$-44.47M
1W Performance:
-5.08%
1M Performance:
-2.61%
6M Performance:
-41.97%
1Y Performance:
-60.42%
1-Day Range:
$1.10
$1.14
1-Week Range:
$1.08
$1.195
52-Week Range:
$0.8645
$3.08
Tela Bio Inc Stock (TELA) Company Profile
Name
Tela Bio Inc
Sector
Industry
Phone
484-320-2930
Address
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Compare TELA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
1.12 | 50.54M | 63.15M | -40.30M | -44.47M | -1.67 |
|
ABT
Abbott Laboratories
|
127.03 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.67 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.58 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.76 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.85 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-21-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-31-22 | Initiated | Lake Street | Buy |
| Dec-03-19 | Initiated | Canaccord Genuity | Buy |
| Dec-03-19 | Initiated | JMP Securities | Mkt Outperform |
| Dec-03-19 | Initiated | Jefferies | Buy |
| Dec-03-19 | Initiated | Piper Jaffray | Overweight |
View All
Tela Bio Inc Stock (TELA) Latest News
TELA Bio introduces LIQUIFIX for enhanced surgical precision - Traders Union
Is TELA Bio Inc. stock in correction or buying zone2026 world cup usa national team round of 32 young talents transition play winner prediction breakdown - ulpravda.ru
TELA Bio to Present at Canaccord Genuity 45th Annual Growth Conference - MSN
TELA Bio Appoints Healthcare Leader Betty Jo Rocchio to Board of Directors - MSN
Is It Too Late to Sell PVV Infra LimitedLong-Term Investment Plans & Outstanding Wealth Building - earlytimes.in
TELA Bio Inc Stock Analysis and ForecastVolatility Trading Techniques & Minimal Investment Profits - earlytimes.in
Movement Recap: How TELA Bio Inc stock reacts to bond yieldsJuly 2025 Sector Moves & Long-Term Safe Investment Ideas - moha.gov.vn
Small Medtech TELA Bio Takes On Becton Dickinson, Alleges Hernia Mesh Monopoly - Benzinga
Becton, Dickinson accused of hindering competition in hernia mesh market - MSN
Becton Muscles Out Hernia Mesh Rivals, Antitrust Suit Says - Law360
Tela Bio (TELA) Sues Becton, Dickinson Over Hernia Mesh Market P - GuruFocus
Medical device maker Becton Dickinson sued over alleged hernia mesh monopoly - Reuters
Is TELA Bio Inc. stock a top pick in earnings seasonWeekly Market Outlook & Smart Swing Trading Techniques - Улправда
How sustainable is TELA Bio Inc. stock dividend payoutQuarterly Portfolio Summary & Growth Focused Entry Point Reports - Улправда
Will TELA Bio Inc. stock continue dividend increasesWeekly Trading Summary & Reliable Breakout Stock Forecasts - Улправда
How TELA Bio Inc. stock reacts to bond yields2025 Bull vs Bear & Weekly Momentum Stock Picks - DonanımHaber
Becton Dickinson Faces Antitrust Suit Over Hernia Mesh Products - Bloomberg Law News
Whale Trades: Is TELA Bio Inc. stock a top pick in earnings seasonMarket Growth Review & Daily Stock Trend Watchlist - Улправда
Update Report: Is TELA Bio Inc. stock gaining market shareJuly 2025 Opening Moves & Safe Entry Momentum Tips - ulpravda.ru
TELA Bio signals growth with new-hire equity grants - MSN
Is TELA Bio Inc. stock gaining market shareTrade Volume Report & Risk Managed Investment Signals - Улправда
Canaccord Genuity Keeps Their Buy Rating on TELA Bio (TELA) - The Globe and Mail
TELA Bio Signals Growth With New-Hire Equity Grants - MyChesCo
TELA Bio Earnings Notes - Trefis
TELA Bio (TELA) price target decreased by 25.81% to 3.52 - MSN
Lake Street Keeps Their Buy Rating on TELA Bio (TELA) - The Globe and Mail
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Associated Press | syndication news - Enidnews.com
What analysts say about TELA Bio Inc stockTrading Volume Surges & High Return Capital Growth - earlytimes.in
TELA Bio, Inc. (NASDAQ:TELA) Receives $3.25 Consensus Price Target from Analysts - Defense World
Resistance Check: Is TELA Bio Inc stock gaining market shareMarket Performance Summary & Entry Point Strategy Guides - BỘ NỘI VỤ
TELA Bio (TELA) Stock Analysis Report | Financials & Insights - Benzinga
Analysts Offer Insights on Healthcare Companies: TELA Bio (TELA) and Centessa Pharmaceuticals (CNTA) - The Globe and Mail
TELA Bio stock price target lowered to $3 by Lake Street on sales issues - Investing.com South Africa
Lake Street Maintains TELA Bio (TELA) Buy Recommendation - Nasdaq
Lake Street Lowers Price Target for TELA Bio (TELA) Amid Continued Buy Rating | TELA Stock News - GuruFocus
TELA Bio, Inc. Experiences Revision in Its Stock Evaluation Amid Mixed Financial Performance - Markets Mojo
TELA Bio Set to Spotlight Soft-Tissue Innovations at Major Healthcare Conference - MSN
TELA Bio Unveils New Wave of Hiring With Stock Grants Tied to Growth Push - MSN
TELA Bio Posts Steady Growth as Strategic Shift Sparks New Commercial Momentum - MSN
Goodwin Advises TELA Bio On $13 Million Underwritten Registered Direct Offering And Credit Refinancing - Mondaq
How to track smart money flows in TELA Bio Inc.2025 AllTime Highs & Consistent Return Strategy Ideas - newser.com
What MACD signals say about TELA Bio Inc.July 2025 Setups & Weekly High Return Forecasts - newser.com
Measuring TELA Bio Inc.’s beta against major indicesPortfolio Value Summary & High Accuracy Trade Signal Alerts - newser.com
Tela Bio Inc Stock (TELA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.20%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):